Moderate to severe COPD (post-bronchodilator forced expiratory volume in 1 s (FEV1) 30-79%predicted);
Resting functional residual capacity (FRC) >120% predicted;
Clinically stable and on stable triple therapy with an ICS/LABA and tiotropium;
Symptomatic: Baseline Dyspnea Index =8 and answer "in the morning" when asked about what time of day their COPD symptoms are worst.
